Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 1977688)

Published in Br J Cancer on October 01, 1991

Authors

J M Moseley1, J A Danks, V Grill, T A Lister, M A Horton

Author Affiliations

1: St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

Articles cited by this

Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69

A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (1987) 4.09

Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67

Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med (1990) 2.76

Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1988) 2.20

Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med (1983) 1.58

Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res (1989) 1.28

Parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol (Oxf) (1989) 1.25

Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med (1988) 1.10

Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J Clin Invest (1988) 1.06

The spectrum of metabolic bone disease in lymphoblastic leukemia. Cancer (1987) 1.06

The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. Ann Intern Med (1983) 1.05

Parathyroid hormone-related protein in adult T-cell leukemia-lymphoma. Ann Intern Med (1989) 1.04

Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology (1988) 1.01

The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood (1984) 1.01

Hypercalcemia and osteoclast proliferation in adult T-cell leukemia. Cancer (1987) 0.98

Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood (1989) 0.96

Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type I-infected T cell line. Biochem Biophys Res Commun (1988) 0.95

Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes. Cancer Res (1989) 0.90

Caribbean T-cell lymphoma/leukemia. Cancer (1984) 0.88

Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages. J Pathol (1989) 0.85

Adult T-cell leukemia. Blood Rev (1988) 0.83

Hypercalcaemia and serum TNF-alpha in T-cell leukaemia. Lancet (1990) 0.79

Hypercalcaemia of malignancy. Cancer Metastasis Rev (1989) 0.78

Articles by these authors

(truncated to the top 100)

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42

Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ (1994) 3.52

Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94

The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol (1999) 2.84

Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71

The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71

Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51

Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34

Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29

Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol (2000) 2.19

Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15

Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. J Bone Miner Res (2002) 2.12

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05

A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci U S A (1995) 1.95

Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93

An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79

Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis. Br J Haematol (2001) 1.79

Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79

Alcohol consumption and type 2 diabetes Meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia (2005) 1.76

Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74

Emotional support for cancer patients: what do patients really want? Br J Cancer (1996) 1.72

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68

Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66

Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet (1983) 1.66

Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63

Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab (1995) 1.60

Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer. J Clin Endocrinol Metab (2001) 1.59

Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. J Clin Oncol (2003) 1.59

Central nervous system toxicity of interferon. Br J Cancer (1983) 1.58

The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol (1991) 1.55

Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res (1990) 1.54

A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment. J Intern Med (2002) 1.52

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51

Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia (2005) 1.50

Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol (1995) 1.48

High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol (1998) 1.48

MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J (1978) 1.46

Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med (2000) 1.45

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet (1993) 1.45

Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood (1994) 1.44

Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol (2000) 1.43

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43

Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43

Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med (1979) 1.42

HLA-DP based resistance to Hodgkin's disease. Lancet (1989) 1.42

Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol (1994) 1.41

Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol (1983) 1.40

Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia. Br J Haematol (1989) 1.40

Parathyroid hormone-related protein in neonatal and reproductive goats determined by a sensitive time-resolved immunofluorometric assay. Eur J Endocrinol (1997) 1.39

Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol (1986) 1.34

The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34

Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28

Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol (2001) 1.28

A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion. Cancer Chemother Pharmacol (1982) 1.26

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J (1978) 1.25

Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells. Biochem Biophys Res Commun (2001) 1.24

Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone (1996) 1.23

Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22

Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases. Br J Haematol (1976) 1.22

Socio-economic position at three points in life in association with type 2 diabetes and impaired glucose tolerance in middle-aged Swedish men and women. Int J Epidemiol (2007) 1.22

Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases. Hematol Oncol (1990) 1.21

Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. J Bone Miner Res (1992) 1.19

Adapting atomic force microscopy for cell biology. Ultramicroscopy (2000) 1.19

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell Mol Life Sci (2004) 1.19

Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer (1979) 1.18

Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology (1997) 1.17

Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol (2005) 1.17

Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia (2007) 1.17

Parathyroid hormone-related protein and hypercalcemia. Cancer (1997) 1.17

Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature (1987) 1.16

The impact of family history of diabetes and lifestyle factors on abnormal glucose regulation in middle-aged Swedish men and women. Diabetologia (2006) 1.16

Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15

A nonradioactive biochemical characterization of membrane proteins using enhanced chemiluminescence. Anal Biochem (1992) 1.15

Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia (2007) 1.14

Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res (1992) 1.14

Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed) (1988) 1.14

Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol (1988) 1.13

Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up. Diabetes Obes Metab (2007) 1.13

Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner (1986) 1.13

Immediate and time-dependent effects of glucose on insulin release from rat pancreatic tissue. Evidence for different mechanisms of action. J Clin Invest (1978) 1.13

Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study. Diabetologia (2006) 1.12

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol (2001) 1.12

Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol (1995) 1.12

Atomic force microscopy can be used to mechanically stimulate osteoblasts and evaluate cellular strain distributions. Ultramicroscopy (2001) 1.11

Activation by glucose of adenyl cyclase in pancreatic islets of the rat. FEBS Lett (1973) 1.10

A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. Cancer Res (1996) 1.10

High resolution dissociative electron attachment to gas phase adenine. J Chem Phys (2006) 1.09

Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology (1996) 1.08